Cincinnati.com: Chronic pain: Would changes in CDC opioid prescribing guidelines help those who have it?
UC expert welcomes the proposed changes
In 2016, the Centers for Disease Control and Prevention (CDC) set opioid-prescribing guidelines for physicians. The idea was to offer doctors the best ways to protect people from an over-prescription of pain pills which had fueled the misuse of opioids and amplified cascading overdose deaths in the United States. While the goal was to protect patients, the impact was not all positive.
Following a backlash of complaints from pain patients, along with years of apparent misinterpretation among physicians and new evidence from studies that have been done since the 2016 guidelines went into effect, the CDC has drafted an updated proposal. The draft is in a public comment period that ends April 11.
In an article published by Cincinnati.com, Christine Wilder, MD, of the Department of Psychiatry and Behavioral Neuroscience at the UC College of Medicine and the director of UC Health Addiction Sciences, was one of the experts quoted on the guideline changes, which she says she welcomes.
"I think (the original set) was adopted as ‘the rules’ by a lot of physicians, states, medical boards … who then required things such as explanations for any more than a seven-day prescription of medication. These are partly a response to that," she said.
Wilder told Cincinnati.com that after the 2016 guidelines came out, she saw an uptick in chronic pain patients asking for methadone treatment at the UC opioid treatment program – because their pain medication had been abruptly stopped or they had one negative drug screen.
"Physically they feel terrible," Wilder said. But some of the patients could not be treated with methadone at the clinic. "Legally for methadone, you can’t admit someone to the clinic unless someone had opioid use disorder." That's not what they had. They were experiencing withdrawal because of their physical dependence on the medication, not addiction.
Lead photo of Christine Wilder, MD/Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.